GROUPAMA / 2018 Registration document

4 CORPORATE SOCIAL RESPONSIBILITY (CSR) GROUPAMA’S 2018 EXTRA-FINANCIAL PERFORMANCE REVIEW A strong commitment since 2000 Three million people in France and 25 million people throughout Europe are affectedby rare diseases:“rare” becauseeach of these 7,000 pathologies affects fewer than 30,000 individuals in France. However, in France overall, they affect 1 person out of every 20. Since 2000, Groupama has been committed to this public interest issue, which is perfectly consistent with its mission as a responsible insurer and mutual insurer. For almost 20 years, the GroupamaFoundationhas supportedmore than 160 organisation, funded more than600 projects, anddonated more than €7 million. The Groupama Health Foundation supports the fight against rare diseases,today public health prioritieswith cancer and Alzheimer’s disease. The goal of the 2016-2018 action plan is to make the Foundation a major illustration of mutual insurance while positioning it as a private player of reference in the field of rare diseases. To achieve this result, strategic focuses were defined, around proximity/solidarity and research/innovation. The 2019-2023 action plan was validated by the Board of Directorsat the end of 2018. Groupama revealed the findings of the 2018 edition of the OpinionWay survey for Groupama, which focused on the French perception of the daily lives of patients. They show significant discernment about the difficulties encountered by patients (82%); this realism is encouraging because it constitutes an essential basis in the fight against rare diseases, even though they underestimatesome of the difficulties that patients may encounter (83%). To strengthen the mobilisation of employees and elected representatives in the fight against rare diseases “Let’s mobilise against rare diseases.”With the goal of developing engagement during the “Semaine de la Fondation” (“Week of the Foundation”), employees were called on to choose from among selected projects the one that they wished to see the Foundation support. A starter donation of €2,500 was given to the favourite project: the charity “Les Enfants de la Lune”. Seven hundred Group employees participated in 2018. Another vector for mobilisation of elected representatives are the “Balades solidaires” (“Solidarity Walks”). They have taken place each year for more than five years throughout France on the first Sunday in June (for the most part). All regional mutuals participate in the event. In 2018, the “Balades solidaires”, organised by the federations of elected representatives and the Groupama Health Foundation, brought together 25,000 walkers in 100 walks and raised nearly €300,000, assisted 53 charities, and supported two female researchers. Constantly growing results since the first edition. Other solidarity events organised by the regional mutuals (concerts, “customer smiles”, sales, etc.) raised just over €41,000 in 2018. Increase efforts to aid medical and medico-social research The Foundation wishes to strengthen its support for research through several actions. The new “Rare Diseases Research Prize”

launched in 2017 (€500,000, paid in instalments over five years) aims to support a dynamic team, led by a senior researcher who has paved an ambitious way to fight rare diseases, to make real advances in this area. The first winning team consisted of biologists, biophysicists, and clinicians, located in a CNRS research unit in Paris. It focuses on Intestinal Epithelial Dysplasia (IED), a rare condition affectingchildren. Moreover, the partnership signed in 2015 with Necker Hospital to promote optimal living for children with rare diseases continued and was extended over 2018. It will be extended again in 2019 in response to one of the focuses of the 3 rd Rare Disease Plan announcedon 4 July 2018. A methodologyfor social workers and new tools were created to best support families of young patients with rare diseases.Fifty families participated in the study. In November 2018, the Foundation signed a sponsorship agreement withthe Pasteur Institute to supportthe developmentof a new approach to gene therapy (with “DNA scissors”) for patients with Steinert disease. The GroupamaFoundationjoins forces with the regional mutuals in their partnership with university hospital centres or universities. Examples can be found in Rennes (diagnosisof rare diseases) and Nantes (gene therapy research) with Groupama Loire Bretagne, Bordeaux with Groupama Centre-Atlantique (paediatric cancer), Toulouse with Groupama d’Oc (Prader-Willi), Lille with Groupama Nord-Est (CRACMO), Strasbourg with Groupama Grand Est (Strasbourg university hospitals), and the Paris region (Bichat Hospital for equipmentpurchasesand the Pontoise hospital centre with local mutuals of Groupama Paris Val de Loire). With regard to paediatric cancers, the Foundation and Groupama Centre-Atlantique announced at the end of 2018 its support for two new projects involving the University of Bordeaux (INSERM teams on liver and kidney cancers). In addition, the social innovationprize was awarded in 2018 to the rare disease assessment platform of the Paris-Sud university hospitals for its “Cuisine mobile” project. Awarded a €20,000 grant, the project aims to support children with rare liver metabolism diseases and their families in the dietary monitoring required by these pathologies by setting up educational culinary workshopswithin hospital units. The goal of this prize is to provide support each year for innovative initiatives that mark a significant step forward and a breakthroughfor people with rare diseases and their families. Intensify actions to provide information on rare diseases to reduce wandering diagnosis Since its creation, the Foundationhas been a partner of Orphanet, a unit of INSERM and European reference portal on rare diseases and orphan drugs, and Alliance Maladies Rares, a group of 220 charities taking action to provide information and raise awareness about rare diseases. In 2018, the Foundationsupportedthe project to create a dynamic infographic of Rare Disease Info Services, a “one-stop shop” of information forall concerned.

98

REGISTRATION DOCUMENT 2018 - GROUPAMA ASSURANCES MUTUELLES